Studies using cancer cells in culture and murine tumor xenografts have found that metformin inhibits tumorigenesis by upregulating DICER1 (Blandino et al., 2012), a key enzyme that processes microRNAs (miRNAs). This evidence concerns the gene DICER1 and neoplasm.